Breast Recurrence Score Test Market - Top Companies and Manufacturers

Companies Dominating the Breast Recurrence Score Test Landscape

Genomic Health, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Agendia, Inc.
NanoString Technologies, Inc.
Myriad Genetics, Inc.
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Roche Holdings AG
Biotheranostics, Inc.
Qiagen N.V.
Veracyte, Inc.

Browse Key Market Insights with Data Illustration:

Breast Recurrence Score Test Market Forecast Report 2036

In the News

Agendia acquired Biomedex, a privately held molecular diagnostics company developing novel multi-cancer detection assays using liquid biopsy technology. This acquisition is expected to expand Agendia's portfolio of cancer diagnostic tests and increase its presence in the liquid biopsy market.
Agendia received FDA approval for its ColonPrint blood test, a liquid biopsy assay that is used to detect early-stage colon cancer. This approval marks a significant milestone for Agendia as it expands its product portfolio and offers a minimally invasive option for colon cancer screening.

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of breast recurrence score test is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market Genomic Health, Inc., Agendia, Inc., NanoString Technologies, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Breast Recurrence Score Test Market - Top Companies and Manufacturers

Companies Dominating the Breast Recurrence Score Test Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the major factor driving the growth of the breast recurrence score test market?

What would be the CAGR of the breast recurrence score test market over the forecast period?

Who are the major players dominating the breast recurrence score test market?

Which segment captures the largest market size in the end user segment in the breast recurrence score test market?

Which region will provide more business opportunities for the growth of the breast recurrence score test market in the future?